Over the last 180 days, Aclaris Therapeutics, Inc. insiders sold a net $1.4M of stock across 73 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 68 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $7.8M | $18.7M | $31.2M | $29.8M |
| OPERATING INCOME | $-76.4M | $-141.9M | $-97.4M | $-89.9M |
| NET INCOME | $-64.9M | $-132.1M | $-88.5M | $-86.9M |
| EPS (DILUTED) | -0.53 | -1.71 | -1.27 | -1.33 |
| OPERATING CASH FLOW | $-47.1M | $-20.1M | $-78.3M | $-67.6M |
| CASH | $20.0M | $24.6M | $39.9M | $45.3M |
No password to create and no card required. We store your email address and nothing else.